Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1172.9000 -25.80 (-2.15%)
NSE Jan 12, 2026 15:31 PM
Volume: 689.1K
 

logo
Aurobindo Pharma Ltd.
13 Nov 2018
1172.90
-2.15%
buy
Results Update: Aurobindo Pharma Ltd.
by HDFC Securities
HDFC Securities
Aurobindo Pharma Ltd Q2FY19 results Comment Revenue grew by 11.61% to Rs. 4667.12 Cr in Q2FY19 when compared to the previous quarter. Also, it increased by 7.19% when compared with Q2FY18.
 
Aurobindo Pharma Ltd. is trading below its 30 day SMA of 1201.4
More from Aurobindo Pharma Ltd.
Recommended
IPO wave continues as Amagi Media and Five SMEs open for subscription
| 12 Jan 2026, 06:40PM
Market closes higher, supported by reassuring comments from US Ambassador Sergio Gor on India-US trade ties
Trendlyne Marketwatch | 12 Jan 2026, 04:04PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020